Second Affiliated Hospital, School Of Medicine, Zhejiang University
Clinical trials sponsored by Second Affiliated Hospital, School Of Medicine, Zhejiang University, explained in plain language.
-
New heart valve technique aims to reduce pacemaker risk
Disease control Recruiting nowThis study is testing whether using a slightly smaller replacement heart valve is better than the standard sizing method for patients with a specific type of bicuspid aortic valve. The goal is to see if the smaller valve reduces the need for a pacemaker and improves how well the …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 21:41 UTC
-
Spinal implant trial aims to reconnect movement for paralyzed patients
Disease control Recruiting nowThis study is testing whether a surgically implanted electrical stimulation device can help restore movement and sensation in people with chronic spinal cord injuries in their lower back. Ten participants will have the device implanted and activated, then undergo regular assessme…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 21:40 UTC
-
Robot surgeons take on deadly brain bleeds in groundbreaking trial
Disease control Recruiting nowThis large trial is testing whether a new, less invasive brain surgery guided by artificial intelligence and a robot can help people recover better from a severe type of stroke caused by bleeding in the brain. It will compare this high-tech surgery to standard treatments across f…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 21:40 UTC
-
Cord blood cells engineered to hunt lymphoma in early trial
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of a new cell therapy for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to standard treatments. Doctors will give patients specially modified immune cells, called CAR NK cells, wh…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New 'Living Drug' trial offers hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a new type of cell therapy for people with T-cell lymphoma that has come back or hasn't responded to standard treatments. Doctors will give patients immune cells from donated umbilical cord blood that have been specially engineered in a lab to find and attac…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New Alzheimer's drug under Real-World watch
Disease control Recruiting nowThis study follows 120 people with early Alzheimer's disease who are receiving the medication Lecanemab. Researchers will track patients for 18 months to see how their memory and thinking skills change and to monitor for any side effects. The goal is to better understand how well…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New immune cell therapy tested for Tough-to-Treat colon cancer
Disease control Recruiting nowThis early-stage trial is testing the safety and finding the right dose of a new CAR-T cell therapy for people with advanced colorectal cancer that has spread to the lining of the abdomen. The therapy involves collecting a patient's own immune cells, modifying them in a lab to at…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New radiation combo aims to hold back advanced lung cancer
Disease control Recruiting nowThis study is testing if a specialized form of radiation, called spatially fractionated radiotherapy (SFRT), can help control advanced lung cancer when added to a patient's current drug therapy. It is for people whose non-small cell lung cancer has spread to only a few new spots …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New combo therapy aims to shrink tumors in Tough-to-Treat colon cancer
Disease control Recruiting nowThis study is testing a new combination of drugs for people with advanced colorectal cancer that has spread and worsened after their first treatment. The goal is to see if adding an immunotherapy drug (AK104) to standard chemotherapy and targeted therapy can shrink tumors and con…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New Two-Pronged cell therapy offers hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy called CD19/BCMA CAR-T for adults with multiple myeloma that has come back or stopped responding to standard treatments. Doctors will collect and modify a patient's own immune cells to attack the cancer, then infuse th…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New drug trial aims to stabilize dangerous heart plaque
Disease control Recruiting nowThis study is testing whether adding a PCSK9 inhibitor drug to standard cholesterol-lowering therapy is better at preventing serious heart and stroke events in people with high-risk plaque in their heart arteries. The plaque is identified using a special, non-invasive CT scan. Re…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New High-Tech lenses aim to restore full vision for complex cataract cases
Disease control Recruiting nowThis study is testing new multifocal lens implants for cataract patients who also have other eye structure problems, like a dislocated lens or a history of eye inflammation. Researchers will use advanced imaging during surgery to precisely place these lenses, which are designed t…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New eye injection aims to halt scarring from herpes infection
Disease control Recruiting nowThis study is testing a new way to deliver a drug directly into the cornea to treat blood vessel growth caused by herpes eye infections. Researchers are injecting the medication into the middle layer of the cornea to see if it is safe and effective at reducing scarring and improv…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Heart attack breakthrough? new 'Leave-Nothing-Behind' balloon treatment tested against standard stents
Disease control Recruiting nowThis study is testing whether a newer, 'leave-nothing-behind' treatment using a drug-coated balloon is as good as the standard treatment using a drug-eluting stent for people having a major heart attack (STEMI). Researchers will enroll about 1,244 patients across China and random…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Needle-in-Eye surgery trial aims to save vision after artery blockage
Disease control Recruiting nowThis study is testing whether a new surgical procedure can help restore vision after a sudden blockage in the eye's main artery. The procedure involves a tiny needle to deliver clot-busting medication directly into the blocked artery, combined with a standard eye surgery. Researc…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New hope for controlling painful Crohn's blockages
Disease control Recruiting nowThis study is observing how well the drug ustekinumab, as part of a broader treatment plan, helps people with Crohn's disease who have developed painful intestinal narrowings (strictures). It will follow 239 patients for up to two years to see if the treatment successfully contro…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New anesthetic aims to stop dangerous blood pressure drops in elderly surgery patients
Disease control Recruiting nowThis study is testing if a newer anesthetic drug called ciprofol helps keep blood pressure more stable during surgery compared to the commonly used drug propofol. It focuses on older patients (65+) who take long-term blood pressure/heart medications, as they are at higher risk fo…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Spinal implant trial aims to help paralyzed patients walk again
Disease control Recruiting nowThis study is testing whether a surgically implanted electrical stimulator can help people with chronic spinal cord injuries regain movement and feeling. Ten participants will have the device placed in their spine and receive personalized stimulation settings during rehabilitatio…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug cocktail aims to shrink tumors before esophageal cancer surgery
Disease control Recruiting nowThis study is testing a combination of three drugs given before surgery for esophageal cancer. The goal is to see if this pre-surgery treatment can shrink tumors more effectively, making surgery more successful and reducing the chance of the cancer coming back. Researchers will e…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
CT scans vs. pills: which is better for your heart?
Disease control Recruiting nowThis study aims to find out whether using a special CT scan to guide heart procedures works better than medication alone for people with chronic chest pain. Researchers will compare two approaches: one group gets procedures based on CT scan results, while the other group receives…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo tested for Tough-to-Treat sarcoma
Disease control Recruiting nowThis study is testing whether a combination of two drugs, cadonilimab and anlotinib, can help control advanced soft tissue sarcoma that has continued to grow after standard first-line chemotherapy. It will involve about 27 adults to see if the treatment shrinks tumors and is safe…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Doctors test smart cancer treatment that changes based on patient response
Disease control Recruiting nowThis study is testing a personalized approach to treating early-stage HER2-positive breast cancer before surgery. All participants start with standard chemotherapy and targeted drugs. Doctors then check how well the tumor is responding. Patients with a good response continue the …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough breast cancers: radiation boost before surgery
Disease control Recruiting nowThis trial is for people with breast cancer whose tumors have not shrunk after two rounds of standard chemotherapy before surgery. It tests if adding a short, targeted course of radiation (SBRT) to the continuing chemotherapy can better eliminate the cancer and allow for breast-c…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for Crohn's patients when standard treatment fails
Disease control Recruiting nowThis study is testing whether guselkumab can help control Crohn's disease in patients whose previous ustekinumab treatment stopped working or caused side effects. Researchers will follow 60 adults with moderate to severe Crohn's disease for one year while they receive guselkumab …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Robot surgeons guided by AI target devastating brain bleeds
Disease control Recruiting nowThis trial is testing whether a new AI-guided robotic system can improve surgery for a type of severe stroke called a basal ganglia hemorrhage. It will compare this high-tech, minimally invasive approach to standard care in 330 patients across multiple hospitals in China. The mai…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New device aims to suck out kidney stones during surgery
Disease control Recruiting nowThis study is testing a new surgical tool called VISOR for people with kidney or ureter stones. The goal is to see if it can safely break up and remove stones in one procedure, aiming to leave very few fragments behind. Participants will have surgery with the device and then get …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Heart valve showdown: Less-Invasive procedure vs. open surgery
Disease control Recruiting nowThis large study aims to find out which of two procedures is better for treating severe aortic regurgitation, a condition where a heart valve leaks. It will compare a newer, less-invasive procedure (TAVR) with traditional open-heart surgery (SAVR) in 1,250 patients aged 65 and ol…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for deadliest brain cancer: direct chemo injection trial
Disease control Recruiting nowThis study is testing if adding a direct spinal fluid chemotherapy injection to standard brain cancer treatment helps adults with a particularly aggressive form of glioblastoma (GBM) that has spread to brain fluid spaces. The goal is to see if this combined approach can better co…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Double-Punch immunotherapy trial aims to boost survival in tough head and neck cancers
Disease control Recruiting nowThis study is testing whether adding a new two-drug immunotherapy (iparomlimab and tuvonralimab) to standard radiation and chemotherapy can better control advanced head and neck cancer. It will involve 27 adults with newly diagnosed, locally advanced cancer who haven't had prior …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Seaweed protein tested as potential liver disease treatment
Disease control Recruiting nowThis study is testing whether a natural protein from spirulina algae, called phycocyanin, can help treat liver scarring (fibrosis and cirrhosis). Researchers will give the supplement or a placebo to 10 adult patients for at least 4 weeks to see if it reduces liver stiffness and l…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Tiny stent tested to fight glaucoma during cataract operation
Disease control Recruiting nowThis study is testing whether adding a tiny device called an iStent during cataract surgery helps lower eye pressure in people who also have glaucoma. Researchers will compare patients who get the stent with their cataract surgery to those who get cataract surgery alone. The goal…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Head-to-Head drug battle to stop Crohn's patients needing surgery
Disease control Recruiting nowThis study aims to see which of two existing biologic drugs, guselkumab or ustekinumab, works better for people with Crohn's disease who have developed a narrowing (stricture) in their bowel. It will follow 100 adults for a year to see if the drug successfully controls their dise…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Allergy pill could be new lifesaver for heart attack survivors
Disease control Recruiting nowThis study is testing if a common allergy medicine, fexofenadine (like Allegra), can help people who recently had a major heart attack. It will involve 2,804 participants who will take the drug or a placebo for two years. The main goal is to see if it reduces the risk of having a…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Zapping anxiety: can brain stimulation ease social fears?
Disease control Recruiting nowThis study is testing whether a non-invasive brain stimulation technique can help reduce symptoms of social anxiety disorder. One hundred participants will receive either real or sham stimulation to the forehead area over one week. Researchers will track changes in anxiety levels…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for keeping aggressive blood cancer at bay
Disease control Recruiting nowThis study aims to find the best maintenance therapy to help keep high-risk multiple myeloma from returning after initial treatment. It will compare two oral drug combinations in 100 patients who have already completed standard therapy. The goal is to see which approach keeps pat…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Spray-On chemo tested in battle against advanced colon cancer
Disease control Recruiting nowThis early-stage study is testing a new way to deliver chemotherapy directly into the abdomen for people with colorectal cancer that has spread there. Doctors spray the chemo as a pressurized mist during a minimally invasive procedure, hoping it will better target the cancer. The…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for tough head & neck cancers: trial tests smart drug timing
Disease control Recruiting nowThis study is testing a new combination of drugs given before surgery for people with advanced head and neck cancer. The goal is to see if adding a specific immune-modulating drug (a JAK1 inhibitor) to standard immunotherapy and chemotherapy can shrink tumors more effectively. Re…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for 'Chemo-Resistant' breast cancer: radiation + immunotherapy combo trial
Disease control Recruiting nowThis trial tests a 'rescue' strategy for patients with triple-negative breast cancer whose tumors don't shrink after initial chemotherapy. Participants receive a short, precise radiation treatment followed by immunotherapy combined with two chemotherapy drugs, aiming to shrink tu…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New brain cancer combo therapy enters human testing
Disease control Recruiting nowThis study is testing whether a combination of whole-brain radiation and a chemotherapy drug injected into the spinal fluid is safe and effective for treating cancer that has spread to the lining of the brain and spinal cord. It will involve 58 adults with solid tumors who have t…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New 'Armored' cell therapy tested in fight against deadly brain cancer
Disease control Recruiting nowThis is a first-in-human, early-stage trial testing the safety and initial effectiveness of a new type of CAR-T cell therapy called EPC-003 for adults with recurrent or treatment-resistant glioblastoma, a serious brain cancer. The therapy involves collecting and genetically modif…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can a special diet stop Crohn's from coming back after surgery?
Disease control Recruiting nowThis study is testing a new dietary plan designed to help Chinese patients with Crohn's disease stay in remission after having bowel surgery. It aims to see if this specific diet can improve quality of life and nutritional health better than current approaches. The diet is based …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
One stitch or two? heart valve study aims to prevent dangerous bleeding
Disease control Recruiting nowThis study is comparing two techniques for closing the artery after a minimally invasive heart valve replacement (TAVR). Researchers want to see if using one special closure device works as well as using two devices to prevent bleeding and other complications at the leg entry sit…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Doctors question routine steroid use before IBD infusions
Disease control Recruiting nowThis study is looking at whether patients with moderate-to-severe Crohn's disease or ulcerative colitis need to take a steroid pill (dexamethasone) before receiving their infliximab infusion to prevent allergic reactions. Researchers want to see if skipping this pre-medication fo…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New transplant strategy aims to stop lymphoma from spreading to the brain
Disease control Recruiting nowThis study is testing a modified chemotherapy regimen given before a patient's own stem cells are transplanted back into them. It is for people with non-Hodgkin lymphoma who are at high risk of the cancer spreading to their brain or spinal cord. The goal is to see if this approac…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Seaweed supplement trial aims to boost liver recovery after cancer operation
Disease control Recruiting nowThis study is testing whether taking spirulina tablets can help protect the liver and help it heal faster after surgery to remove part of it for bile duct cancer. Researchers will give 30 participants either spirulina or a placebo pill for 3 weeks before and 3 weeks after their o…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Spinal implant offers new hope for walking after paralysis
Disease control Recruiting nowThis study is testing whether a surgically implanted spinal cord stimulator, combined with intensive physical therapy, can help people with certain spinal cord injuries walk better. Researchers will implant the device in 12 participants and measure their walking ability, independ…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Amino acid boosts cancer treatment? new study tests leucine combo
Disease control Recruiting nowThis study is testing if adding a common amino acid called leucine to the standard pre-surgery treatment (chemotherapy and radiation) can help shrink tumors more effectively in people with locally advanced rectal cancer. The goal is to see if this combination leads to better outc…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists test 'Living Drug' virus to hunt down stubborn lymphoma
Disease control Recruiting nowThis early-stage study is testing a new treatment for B-cell lymphoma that has come back or not responded to other therapies. The treatment uses a modified virus designed to both attack cancer cells directly and instruct the patient's own immune system to target them. Researchers…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New hope for advanced colon cancer patients after first treatment fails
Disease control Recruiting nowThis study is testing whether a new version of an existing chemotherapy drug, packaged in tiny fat bubbles called liposomes, works better and is safer when combined with other cancer drugs for advanced colorectal cancer. It's for patients whose first treatment has stopped working…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
First-in-Human trial tests universal mRNA shot against deadly brain cancer
Disease control Recruiting nowThis early-stage trial is testing the safety of a new type of personalized mRNA vaccine designed to treat aggressive brain tumors that have returned or worsened after standard treatment. The study will enroll 10 patients to see if the vaccine is safe and if it can trigger the imm…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Can radiation stop tongue cancer from coming back?
Disease control Recruiting nowThis study is testing if adding radiation therapy after surgery helps prevent early-stage tongue cancer from returning in patients who have certain risk factors. Researchers will compare two groups: one that receives radiation after surgery and one that is simply monitored. They …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Engineered immune cells target devastating autoimmune diseases in groundbreaking trial
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for people with severe autoimmune diseases that haven't improved with standard treatments. Doctors will give patients specially engineered immune cells (CAR-NK cells) to try to reset their overactive immune systems. The main go…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC
-
New drug trial targets rare, aggressive sarcoma
Disease control Recruiting nowThis study is testing an oral drug called vebreltinib for people with advanced clear cell sarcoma, a rare and aggressive cancer. It aims to see if the drug can shrink tumors and control the disease. The trial will enroll about 30 patients and compare their outcomes to a group rec…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug called pucotenlimab to the standard pre-surgery treatment (chemotherapy and radiation) works better for people with locally advanced rectal cancer. The goal is to see if this combination helps more patients achieve a c…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New immune cell therapy tested for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new type of personalized immune cell therapy called CAR-T for people with advanced lung or breast cancer that has stopped responding to standard treatments. The therapy involves collecting a patient's own immune cells, modifying them in a lab t…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
New hope for tough leukemia: First-in-Human trial of targeted cell therapy begins
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy called LILRA6 CAR-T for adults whose acute myeloid leukemia has come back or hasn't responded to standard treatments. The main goals are to find a safe dose and see if the therapy can help control the cancer. This is a…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Feb 23, 2026 14:54 UTC
-
AI steps in to spot brain tumors, could reduce risky biopsies
Diagnosis Recruiting nowThis study aims to develop an artificial intelligence (AI) system to help doctors more accurately diagnose common malignant brain tumors from MRI scans. It will use images and confirmed diagnoses from 3,000 adults with brain tumors to train and test the AI. The goal is to create …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
AI reads scans to pinpoint lung cancer type
Diagnosis Recruiting nowThis study is testing a new artificial intelligence (AI) system designed to analyze PET/CT scans and patient information. The goal is to help doctors more accurately determine the specific subtype of a patient's lung cancer and predict certain genetic features, all from the scan …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Apr 02, 2026 14:58 UTC
-
AI tool could forecast which breast cancers will spread
Diagnosis Recruiting nowThis study aims to develop an artificial intelligence (AI) tool that can predict whether breast cancer will spread to other parts of the body. Researchers will analyze existing tissue samples from 400 patients who had breast cancer surgery between 2015 and 2025. The AI will exami…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Could a simple eye scan spot Parkinson's years earlier?
Diagnosis Recruiting nowThis study is testing if a quick, non-invasive scan of the back of the eye (the retina) can help doctors diagnose Parkinson's disease in its early stages. Researchers will compare the eye scan's accuracy to a more complex and expensive brain scan currently used for diagnosis. The…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
AI heart detective: can computers spot hidden heart disease?
Diagnosis Recruiting nowThis study is testing whether artificial intelligence (AI) can help doctors better diagnose and classify hypertrophic cardiomyopathy, a serious heart muscle disease. Researchers will use AI to analyze standard heart tracing tests (ECGs) from 15,000 participants to see if it can a…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
Scientists build 3D eye maps to guide complex cataract surgery
Diagnosis Recruiting nowThis study is testing a new method to create a detailed 3D computer model of the entire eye. The goal is to help doctors better understand complex eye conditions, like difficult cataracts, before surgery. Researchers will combine several imaging scans to build the model, hoping i…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC
-
Blood test could predict painful dry mouth from cancer radiotherapy
Diagnosis Recruiting nowThis study aims to find early warning signs in the blood that can predict which cancer patients will develop severe, painful dry mouth after radiotherapy. Researchers will collect blood samples from 126 head and neck cancer patients before and after their treatment. The goal is t…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 06, 2026 15:38 UTC
-
Breakthrough study tests two paths to unfreeze painful shoulders
Symptom relief Recruiting nowThis study aims to find out which treatment works better for early frozen shoulder (adhesive capsulitis). Researchers are comparing a medical procedure done under anesthesia with a supervised home exercise program. The trial will involve 300 adults aged 40-80 who have had shoulde…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Apr 03, 2026 21:40 UTC
-
Butt shot vs. shoulder shot: which eases frozen shoulder better?
Symptom relief Recruiting nowThis study is testing if a steroid injection in the buttock muscle works as well as a more precise, ultrasound-guided injection directly into the shoulder joint for treating frozen shoulder. Researchers will enroll 528 adults with painful, stiff shoulders to compare how much pain…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Can common painkillers replace opioids after surgery?
Symptom relief Recruiting nowThis study tests whether a combination of common non-opioid pain medications (celecoxib and acetaminophen) works as well as opioid-based pain relief for patients recovering from minimally invasive ankle surgery. Researchers will compare pain levels and side effects in 110 adults …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Scientists pinpoint perfect painkiller dose for surgery recovery
Symptom relief Recruiting nowThis study aims to find the best single dose of a pain medication called tegileridine for adults recovering from bone or joint surgery. Researchers will test different doses in 180 patients to see which one effectively controls pain for 90% of people shortly after waking up from …
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Ancient patch eases modern chemo woes
Symptom relief Recruiting nowThis study is testing a traditional Chinese medicine patch applied to specific points on the skin to relieve constipation and fatigue in people with colorectal cancer who are undergoing chemotherapy after surgery. Researchers will compare the patch treatment to standard care in 1…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Poop pills tested to fight cancer drug sickness
Symptom relief Recruiting nowThis study is testing if a fecal microbiota transplant (FMT), which transfers healthy gut bacteria from a donor, can help reduce nausea, vomiting, and diarrhea caused by chemotherapy or targeted therapy. It will involve 90 adults with advanced gastrointestinal cancers who have al…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
Numbing shot before ankle surgery could ease pain, but may slow walking
Symptom relief Recruiting nowThis study is testing if numbing the nerves around the ankle before a common 'keyhole' surgery helps control pain in the first day after the operation. Researchers will compare this approach to a placebo in 70 patients to see if it reduces the need for strong painkillers. They wi…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 17, 2026 12:55 UTC
-
Zapping brain pain: faster treatment tested for chronic nerve suffering
Symptom relief Recruiting nowThis study is testing a new, faster schedule of non-invasive brain stimulation to see if it can better relieve chronic nerve pain. Researchers are comparing this accelerated method against the standard stimulation treatment in 120 adults who have had nerve pain for at least three…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Feb 27, 2026 15:19 UTC
-
Scientists read minds to build future speech devices
Knowledge-focused Recruiting nowThis study aims to understand how the brain imagines speaking Mandarin Chinese, including its unique tones, without actually moving the mouth. Researchers will record brain activity from about 50 adults who are already having brain surgery for conditions like epilepsy or tumors. …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 03, 2026 21:55 UTC
-
Do variceal treatments actually reduce dangerous vein pressure? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand how two common treatments for swollen veins in the esophagus (banding and injection therapy) affect the underlying pressure in the liver's blood vessels over several months. Researchers will measure this pressure using a specialized ultrasound techni…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 03, 2026 21:41 UTC
-
AI analyzes cancer to forecast its next move
Knowledge-focused Recruiting nowThis study aims to develop a computer model that can predict if and where breast cancer might spread in the body. Researchers will use artificial intelligence to analyze detailed information from past patients' tumor samples and medical records. The goal is to create a tool that …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
Massive study follows thousands of liver transplant patients for life
Knowledge-focused Recruiting nowThis study aims to track the long-term health of people who receive liver transplants and those who donate part of their liver. Researchers will follow nearly 10,000 participants over time to understand what factors lead to complications after surgery. The goal is to create bette…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC
-
Scientists zap blood cells to make cancer surgery safer
Knowledge-focused Recruiting nowThis study aims to understand how radiation used during cancer surgery affects a patient's own red blood cells. Researchers will collect blood from 20 cancer patients during surgery and test how different radiation doses change the cells' shape, flexibility, and ability to carry …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC
-
Do tiny heart vessel issues predict major problems?
Knowledge-focused Recruiting nowThis study aims to understand if problems with the heart's smallest blood vessels predict worse outcomes for people with dilated cardiomyopathy, a condition where the heart muscle is weakened and enlarged. Researchers will observe 330 patients with this condition to see if those …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Can ozempic and mounjaro turn back your biological clock?
Knowledge-focused Recruiting nowThis study is investigating whether popular weight-loss medications like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) can slow down or reverse accelerated aging at the genetic level in adults with obesity. Researchers will enroll 66 adults with obesity and mea…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Scientists track lung bacteria for 3 years to predict deadly Flare-Ups
Knowledge-focused Recruiting nowThis study aims to understand how bacteria in the lungs of people with bronchiectasis change over time. Researchers will collect sputum samples from 1850 patients every month for three years to analyze these bacteria. The goal is to learn if changes in these bacteria can predict …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Could your breath help doctors keep you asleep during surgery?
Knowledge-focused Recruiting nowThis study is testing a new method to help doctors control how deeply a patient is asleep during surgery. Researchers will measure the levels of anesthetic drugs in a patient's exhaled breath in real-time and see how well this matches the patient's brain activity. The goal is to …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Massive 10,000-Person study aims to predict heart valve failure
Knowledge-focused Recruiting nowThis study aims to understand how moderate heart valve disease gets worse over time. It will follow 10,000 adults in China, using regular heart scans and blood tests to track their condition. The goal is to find early warning signs and see how different treatments affect the dise…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC
-
Scientists hunt for Brain's 'Fingerprint' in depression and schizophrenia
Knowledge-focused Recruiting nowThis study aims to find objective biological markers in the brain to help diagnose and track treatment for severe mental disorders like depression, schizophrenia, and bipolar disorder. Researchers will use a powerful 7T MRI scanner and vision tests to compare brain chemistry and …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC